Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003624
Status:
TERMINATED
Last Update Posted:
2013-04-11
First Post:
1999-11-01
Brief Title:
Amifostine in Treating Women With Ovarian Peritoneal Cervical Fallopian Tube Uterine or Endometrial Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sarcoma |
| Cervical Cancer |
| Endometrial Cancer |
| Fallopian Tube Cancer |
| Neurotoxicity |
| Ovarian Cancer |
| Primary Peritoneal Cavity Cancer |
Keywords:
| Name | View |
|---|---|
| neurotoxicity | View |
| stage I cervical cancer | View |
| stage II cervical cancer | View |
| stage III cervical cancer | View |
| stage IV cervical cancer | View |
| stage I ovarian epithelial cancer | View |
| stage II ovarian epithelial cancer | View |
| stage III ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| stage I endometrial carcinoma | View |
| stage II endometrial carcinoma | View |
| stage III endometrial carcinoma | View |
| stage IV endometrial carcinoma | View |
| endometrial adenocarcinoma | View |
| fallopian tube cancer | View |
| primary peritoneal cavity cancer | View |
| stage I uterine sarcoma | View |
| stage II uterine sarcoma | View |
| stage III uterine sarcoma | View |
| stage IV uterine sarcoma | View |